medigraphic.com
Instituto Nacional de Salud Pública

2011, Number 5

<< Back Next >>

salud publica mex 2011; 53 (5)

Genetics of breast cancer: Applications to the Mexican population

Ziv E

Language: English
References: 49
Page: 415-419
PDF size: 167.01 Kb.


ABSTRACT

Breast cancer research has yielded several important results including the strong susceptibility genes, BRCA1 and BRCA2 and more recently 19 genes and genetic loci that confer a more moderate risk. The pace of discovery is accelerating as genetic technology and computational methods improve. These discoveries will change the way that breast cancer risk is understood in Mexico over the next few decades.


REFERENCES

  1. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71(5):800-9.

  2. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48(2):232-42.

  3. Claus EB, Risch NJ, Thompson WD. Using age of onset to distinguish between subforms of breast cancer. Ann Hum Genet 1990;54(Pt 2):169-77.

  4. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131(6):961-72.

  5. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-- analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343(2):78-85.

  6. Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000;26(4):411-4.

  7. Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10(7):733-41.

  8. Burchard EG, Borrell LN, Choudhry S, Naqvi M, Tsai HJ, Rodriguez- Santana JR, et al. Latino Populations: A Unique Opportunity for the Study of Race, Genetics, and Social Environment in Epidemiological Research. Am J Public Health 2005.

  9. Collins-Schramm HE, Chima B, Morii T, Wah K, Figueroa Y, Criswell LA, et al. Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians. Hum Genet 2004;114(3):263-71.

  10. Mao X, Bigham AW, Mei R, Gutierrez G, Weiss KM, Brutsaert TD, et al. A genomewide admixture mapping panel for Hispanic/Latino populations. Am J Hum Genet 2007;80(6):1171-8.

  11. Martinez-Marignac VL, Valladares A, Cameron E, Chan A, Perera A, Globus-Goldberg R, et al. Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. Hum Genet 2007;120(6):807-19.

  12. Bonilla C, Gutierrez G, Parra EJ, Kline C, Shriver MD. Admixture analysis of a rural population of the state of Guerrero, Mexico. Am J Phys Anthropol 2005;128(4):861-9.

  13. Halder I, Shriver MD. Measuring and using admixture to study the genetics of complex diseases. Hum Genomics 2003;1(1):52-62.

  14. Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, et al. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci USA 107 Suppl 2:8954-61.

  15. Ziv E, John EM, Choudhry S, Kho J, Lorizio W, Perez-Stable EJ, et al. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 2006;15(10):1878-85.

  16. Fejerman L, Romieu I, John EM, Lazcano-Ponce E, Huntsman S, Beckman KB, et al. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomarkers Prev 19(4):1074-82.

  17. Gorodezky C, Alaez C, Vazquez-Garcia MN, de la Rosa G, Infante E, Balladares S, et al. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 2001;62(9):979-91.

  18. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez- Stable E, et al. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res 2008 1;68(23):9723-8.

  19. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378(6559):789-92.

  20. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266(5182):66-71.

  21. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31(1):33-6.

  22. Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell 2007;11(2):103-5.

  23. Ruiz-Flores P, Sinilnikova OM, Badzioch M, Calderon-Garciduenas AL, Chopin S, Fabrice O, et al. BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 2002;20(6):474-5.

  24. Vidal-Millan S, Taja-Chayeb L, Gutierrez-Hernandez O, Ramirez Ugalde MT, Robles-Vidal C, Bargallo-Rocha E, et al. Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients. Eur J Gynaecol Oncol 2009;30(5):527-30.

  25. Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, Diab S, et al. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 2003;98(3):597-602.

  26. Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. Jama 2005;294(15):1925-33.

  27. John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. Jama 2007;298(24):2869-76.

  28. Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J, et al. Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 2005;14(7):1666-71.

  29. Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, et al. Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 2007;16(8):1615-20.

  30. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42(6):504-7.

  31. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447(7148):1087-93.

  32. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007 Jul;39(7):870-4.

  33. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A 2008;105(11):4340-5.

  34. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40(6):703-6.

  35. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41(5):585-90.

  36. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41(5):579-84.

  37. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009;41(3):324-8.

  38. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362(11):986-93.

  39. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007;39(3):352-8.

  40. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39(7):865-9.

  41. Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, et al. An Admixture Scan in 1,484 African American Women with Breast Cancer. Cancer Epidemiol Biomarkers Prev 2009.

  42. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 2009;18(9):1692-703.

  43. Slattery ML, Baumgartner KB, Giuliano AR, Byers T, Herrick JS, Wolff RK. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res Treat 2011;129(2):531-539.

  44. Reis-Filho JS. Next-generation sequencing. Breast Cancer Res 2009;11 Suppl 3:S12.

  45. Mardis ER, Wilson RK. Cancer genome sequencing: a review. Hum Mol Genet 2009;18(R2):R163-8.

  46. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324(5924):217.

  47. Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, et al. A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer 9(2):181-5.

  48. Heikkinen T, Karkkainen H, Aaltonen K, Milne RL, Heikkila P, Aittomaki K, et al. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 2009;15(9):3214-22.

  49. Hede K. Superhighway or blind alley? The cancer genome atlas releases first results. J Natl Cancer Inst 2008 Nov 19;100(22):1566-9.




2020     |     www.medigraphic.com